Kronos Bio Inc. (NASDAQ: KRON)
$1.40
-0.1000 ( -6.67% ) 231.4K
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
Market Data
Open
$1.40
Previous close
$1.50
Volume
231.4K
Market cap
$84.43M
Day range
$1.35 - $1.51
52 week range
$0.69 - $2.28
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
8-k | 8K-related | 12 | Dec 19, 2023 |
4 | Insider transactions | 1 | Dec 13, 2023 |
4 | Insider transactions | 1 | Dec 13, 2023 |
4 | Insider transactions | 1 | Nov 17, 2023 |
8-k | 8K-related | 14 | Nov 13, 2023 |
10-q | Quarterly Reports | 74 | Nov 13, 2023 |
8-k | 8K-related | 12 | Nov 02, 2023 |